Public source

Reviewed 10 Oct 2026

Completeness Fair (39%)

DiaKwant™ Mitosis

DiaDeep

"DiaKwant™ Mitosis automatically detects invasive tumor regions on H&E slides and identifies mitotic figures.
It highlights candidate mitoses, classifies them, and generates interpretable heatmaps and hotspot-based mitotic scores.
"(https://www.diadeep.com/diakwant)

The DiaKwant™ consists of several algorithms that are a part of a single CE-IVD validated solution.

No papers to support — we monitor for new evidence.

General Information

Product name

DiaKwant™ Mitosis

Company

Modality

Histopathology

Main task

Detection, Quantification

Subspeciality

Breast

Organ/Specimen source

Breast

Disease targeted

Breast Cancer

Specimen type

Not specified

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Regulation (IVDR)

Class:

Class C

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

whole slide image

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

April 2026

AI Platforms

Roche Navify, Sectra

Resellers

Sectra

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Oct 10, 2026 | Last updated: Oct 10, 2026